# Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation

> **NCT04208997** · PHASE3 · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Tachycardia, Ventricular
- Catheter Ablation

## Interventions

- **DRUG:** Antiarrhythmic drug

## Key facts

- **NCT ID:** NCT04208997
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-19
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Study was terminated due to low accrual
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04208997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04208997, "Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04208997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*